Suriñach-Ayats B., Carbonell-Estarellas E., Becerra-Hervas J., López-Bernal E., Boronat S., Moliner-Calderon E.. Epidemiology and characteristics of SARS-CoV-2 infection in the newborn and pregnant woman. Transplacemental transfer of immunoglobulins. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(8)DOI:10.1016/j.eimc.2022.04.009. PMID:35669377. IF:2.600(Q3/6D).

Szabolcs P., Mazor R.D., Yackoubov D., Levy S., Stiff P., Rezvani A., Hanna R., Wagner J., Keating A., Lindemans C.A., Karras N., McGuirk J., Hamerschlak N., López-Torija I., Sanz G., Valcarcel D., Horwitz M.E.. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy. Transplantation And Cellular Therapy. 2023; 29(8)DOI:10.1016/j.jtct.2023.04.018. PMID:37120136. IF:3.600(Q1/3D).

Ortiz A., Ars E., Bernis C., Fraga G., Furlano M., Martínez V., Martins J., Pérez-Gómez M.V., Rodríguez-Pérez J.C., Sans L., Torra R.. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease. Nefrologia. 2023; 43(1)DOI:10.1016/j.nefroe.2022.07.009. PMID:. IF:(Q/D).

Moliner-Calderón E., Verd S., Leiva A., Ginovart G., Moll-McCarthy P., Figueras-Aloy J.. The role of human milk feeds on inotrope use in newborn infants with sepsis. Frontiers in Pediatrics. 2023; 11DOI:10.3389/fped.2023.1172799. PMID:37138570. IF:2.100(Q2/4D).

Baldirà J., Ruiz-Rodríguez J.C., Ruiz-Sanmartin A., Chiscano L., Cortes A., Sistac D.Á., Ferrer-Costa R., Comas I., Villena Y., Larrosa M.N., González-López J.J., Ferrer R.. Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA = 6. Biomedicines. 2023; 11(8)DOI:10.3390/biomedicines11082149. PMID:37626646. IF:3.900(Q1/3D).

Zapata L., Blancas R., Conejo-Márquez I., García-de-Acilu M.. Role of ultrasound in acute respiratory failure and in the weaning of mechanical ventilation. Medicina Intensiva. 2023; 47(9)DOI:10.1016/j.medin.2023.03.009. PMID:. IF:(Q/D).

Ochagavía A., Fraile V., Zapata L.. Introduction to the Update series: Update in intensive care medicine: ultrasound in the critically ill patient. Clinical applications. Medicina Intensiva. 2023; 47(9)DOI:10.1016/j.medin.2023.08.001. PMID:. IF:(Q/D).

Domingo C., Fernandez M., Garin N., Milara J., Moran I., Muerza I., Pacheco A., Teruel C., Bentley R., Subiran R., Gil A.. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis. Applied Health Economics and Health Policy. 2023; 21(1)DOI:10.1007/s40258-022-00770-9. PMID:36319945. IF:3.100(Q2/3D).

Juanes, A, Ruiz, J, Puig, M, Blazquez, M, Gilabert, A, Lopez, L, Baena, MI, Guiu, JM, Mangues, MA. The Effect of the Drug-Related Problems Prevention Bundle on Early Readmissions in Patients From the Emergency Department: A Randomized Clinical Trial. ANNALS OF PHARMACOTHERAPY. 2023; 57(9)DOI:10.1177/10600280221143237. PMID:36539949. IF:2.300(Q3/6D).

Ruiz Ramos J., Ramírez Galleymore P.. Antimicrobial stewardship programs in the intensive care unit in patients with infections caused by multidrug-resistant gram-negative bacilli. Medicina Intensiva. 2023; 47(2)DOI:10.1016/j.medin.2022.07.007. PMID:36319534. IF:2.700(Q2/4D).

Ramos J.R., Hernanz B.C.. [Translated article] Pharmaceutical care in emergency department [Atención Farmacéutica en los servicios de urgencias]. Farmacia Hospitalaria. 2023; 47(3)DOI:10.1016/j.farma.2023.05.001. PMID:37236837. IF:(Q/D).

Martos-Cabrera, L, Llamas-Velasco, M, Armesto, S, Herrera-Acosta, E, Vidal, D, Vilarrasa, E, Rivera-Diaz, R, de la Cueva, P, Martorell-Calatayud, A, Ballesca, F, Belinchon, I, Carretero, G, Rodriguez, L, Romero-Mate, A, Pujol-Montcusi, J, Salgado-Boquete, L, Sahuquillo-Torralba, A, Coto-Segura, P, Baniandres, O, Feltes, R, Alsina, M, Dauden, E. High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(3)DOI:10.1111/ijd.16365. PMID:35867958. IF:3.500(Q1/3D).

Muniesa C., Gallardo F., García-Doval I., Estrach M.T., Combalia A., Morillo-Andújar M., De la Cruz-Vicente F., Machan S., Moya-Martínez C., Rovira R., Sanchez-Gonzalez B., Acebo E., Amutio E., Penate, Y, Losada-Castillo, MD, García-Muret M.P., Iznardo H., Román-Curto C., Canueto, J, Fernández-de-Misa R., Flórez Á., Izu R.M., Torres-Navarro I., Zayas A., Pérez-Paredes G., Blanes M., Yanguas J.I., Pérez-Ferriols A., Callejas-Charavia M., Ortiz-Romero P.L., Pérez-Gil A., Prieto-Torres L., González-Barca E., Servitje O.. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(1)DOI:10.1111/jdv.18563. PMID:36017748. IF:8.500(Q1/1D).

Tous-Romero, F, Gimenez-Arnau, AM, Sanz-Sanchez, T, Perez, RG, Carrascosa-Carrillo, JM, Zaragoza-Ninet, V, Cordoba-Guijarro, S, Gatica-Ortega, ME, Miquel-Miquel, J, Borrego-Hernando, L, Ruiz-Gonzalez, I, Serra-Baldrich, E, Silvester-Salvador, JF, Mercader-Garcia, P, Sanchez-Perez, J, Rodriguez-Serna, M, Pastor-Nieto, A, Hervella-Garcia, M, Garcia-Doval, I, Ortiz-de Frutos, FJ. Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(3)DOI:10.1111/jdv.18595. PMID:36153692. IF:8.500(Q1/1D).

Gonzalez-Cao, M, Puertolas, T, Martinez-Vila, C, Carrera, C, Seral, CM, Rodriguez-Jimenez, P, Sequero, S, Cerezuela-Fuentes, P, Ochoa, RF, Munoz, E, Basa, MA, Martin-Liberal, J, Soria, A, Moreno, JFR, Marquez-Rodas, I, Criado, PL, Manzano, JL, Lopez-Castro, R, De Miguel, PA, Villalobos, L, Algarra, SM, Gonzalez-Barrallo, I, Boada, A, Castano, AG, Puig, S, Crespo, G, Fra, PL, Zamora, CA, Rodriguez, MF, Valles, L, Drozdowskyj, A, Gardeazabal, J, Fernandez-Morales, LA, Rodrigo, A, Cruz, R, Yelamos, O, Rubio, B, Mujica, K, Provencio, M, Berrocal, A. SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry. Clinical & Translational Oncology. 2023; 25(3)DOI:10.1007/s12094-022-02985-7. PMID:36566266. IF:2.800(Q2/5D).

Koren J., Lambert, JLW, Thomsen S.F., McAteer H., Fabbrocini G., Corazza V., Jullien D., Augustin M., Warren R.B., de Rie M.A., Lazaridou E., Puig L., Guillevin L., Grosser M., Boehncke, WH. Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative. Dermatology and Therapy. 2023; 13(1)DOI:10.1007/s13555-022-00846-3. PMID:36484915. IF:3.500(Q1/3D).

Hernández Fernández C.P., Borrego L., Mercader García P., Giménez Arnau A.M., Sánchez Pérez J., Silvestre Salvador J.F., González Pérez R., Sanz Sánchez T., Sánchez Gilo A., Melé Ninot G., Zaragoza Ninet V., Miquel Miquel F.J., Carrascosa Carrillo J.M., Córdoba Guijarro S., Gatica Ortega M.E., Ruiz González I., Serra Baldrich E., Tous Romero F., Rodríguez Serna M., Pastor Nieto M.A., Pérez Feal P., Hervella Garcés M., de Vega Martínez M., García Doval I.. Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation. CONTACT DERMATITIS. 2023; 88(3)DOI:10.1111/cod.14251. PMID:36403138. IF:4.800(Q1/2D).

Yélamos O., Andersen D., Pont M., Iglesias P., Potrony M., Domínguez M., Herrero A., Alejo B., Mateu J., Røpke M., Danneskiold-Samsøe N.B., Malvehy J., Guy R.H., Brix S., Puig S.. Development and validation of a minimally invasive and image-guided tape stripping method to sample atopic skin in children. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023; 48(2)DOI:10.1093/ced/llac040. PMID:36730521. IF:3.700(Q1/2D).

Puig L.. Psoriasis treatment does not impair the immunogenicity of ChAOx1-S[recombinant] COVID-19 vaccination. BRITISH JOURNAL OF DERMATOLOGY. 2023; 188(2)DOI:10.1093/bjd/ljac081. PMID:36763894. IF:11.000(Q1/1D).

Egeberg A., Merola J.F., Schäkel K., Puig L., Mahar P.D., Wang I.Y., Pavo I., Schuster C., Griffiths C.E.M.. Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes. Frontiers in Medicine. 2023; 9DOI:10.3389/fmed.2022.1092688. PMID:36777159. IF:3.100(Q1/2D).